GAO report on GMP harmonization
This article was originally published in The Gray Sheet
Executive SummaryFDA's device center provides the General Accounting Office with comments regarding a GAO draft report on international harmonization of good manufacturing practices. The report, which compares FDA GMPs with those in the European Community, Japan and Canada, was requested by Rep. Henry Waxman (D-Calif.) ("The Gray Sheet" July 27, In Brief). A final copy of the report will be released after GAO considers FDA's comments.
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.